Literature DB >> 19060451

Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection.

Isamu Sugawara1, Satoru Mizuno.   

Abstract

An association between diabetes mellitus and tuberculosis has been implicated for a long time. We have previously reported that Goto Kakizaki type 2 diabetic rats are highly susceptible to Mycobacterium (M.) tuberculosis infection. As a next step, we attempted to clarify whether type 1 diabetic rats are more susceptible to M. tuberculosis than non-diabetic wild-type (WT) rats. Here, we used the Komeda diabetes-prone (KDP) rat, as a model of type 1 diabetes mellitus. The infected KDP rats developed large granulomas without central necrosis in their lungs, liver or spleen. This was consistent with a significant increase in the number of colony-forming units (cfu) of M. tuberculosis in the lungs and spleen (p < 0.01). Insulin treatment resulted in significant reduction of tubercle bacilli in the infected KDP rats (p < 0.01). Pulmonary levels of interferon-gamma, tumor necrosis factor-alpha and interleukin-1beta mRNAs were higher in the infected diabetic rats than in WT rats. Alveolar macrophages from KDP rats were not fully activated by M. tuberculosis infection because the macrophages did not secrete nitric oxide (NO) that can kill M. tuberculosis (p < 0.01), but no significant difference in phagocytosis of tubercle bacilli by alveolar macrophages was observed between KDP and WT rats. Taken together, our findings indicate that type 1 diabetic rats are more susceptible to M. tuberculosis that WT rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060451     DOI: 10.1620/tjem.216.363

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  10 in total

Review 1.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

2.  Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.

Authors:  Therese Vallerskog; Gregory W Martens; Hardy Kornfeld
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

3.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

4.  Aerosol infection model of tuberculosis in wistar rats.

Authors:  Sheshagiri Gaonkar; Sowmya Bharath; Naveen Kumar; V Balasubramanian; Radha K Shandil
Journal:  Int J Microbiol       Date:  2010-03-18

5.  Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study.

Authors:  Anne Leegaard; Anders Riis; Jette B Kornum; Julie B Prahl; Vibeke Ø Thomsen; Henrik Toft Sørensen; C Robert Horsburgh; Reimar W Thomsen
Journal:  Diabetes Care       Date:  2011-10-04       Impact factor: 19.112

6.  The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.

Authors:  Ekta Lachmandas; Frank Vrieling; Louis G Wilson; Simone A Joosten; Mihai G Netea; Tom H Ottenhoff; Reinout van Crevel
Journal:  PLoS One       Date:  2015-02-09       Impact factor: 3.240

Review 7.  Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities.

Authors:  Alba Llibre; Martin Dedicoat; Julie G Burel; Caroline Demangel; Matthew K O'Shea; Claudio Mauro
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

8.  Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective.

Authors:  Roma Sinha; Minh Dao Ngo; Stacey Bartlett; Helle Bielefeldt-Ohmann; Sahar Keshvari; Sumaira Z Hasnain; Meg L Donovan; Jessica C Kling; Antje Blumenthal; Chen Chen; Kirsty R Short; Katharina Ronacher
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 6.073

9.  Increased risk of tuberculosis in patients with type 1 diabetes mellitus: results from a population-based cohort study in Taiwan.

Authors:  Te-Chun Shen; Cheng-Li Lin; Chang-Ching Wei; Wei-Chih Liao; Wei-Chun Chen; Chia-Hung Chen; Chih-Yen Tu; Te-Chun Hsia; Chuen-Ming Shih; Wu-Huei Hsu; Chia-Hsiang Li; Fung-Chang Sung
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 10.  The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.

Authors:  Allison N Bucsan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Pathog Dis       Date:  2019-06-01       Impact factor: 3.166

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.